NO911236L - Fremgangsmaate for fremstilling av haloethyl-substituerte steroidale enzyminhibitorer. - Google Patents

Fremgangsmaate for fremstilling av haloethyl-substituerte steroidale enzyminhibitorer.

Info

Publication number
NO911236L
NO911236L NO91911236A NO911236A NO911236L NO 911236 L NO911236 L NO 911236L NO 91911236 A NO91911236 A NO 91911236A NO 911236 A NO911236 A NO 911236A NO 911236 L NO911236 L NO 911236L
Authority
NO
Norway
Prior art keywords
inhibitors
haloethyl
enzymin
procedure
preparation
Prior art date
Application number
NO91911236A
Other languages
English (en)
Norwegian (no)
Other versions
NO911236D0 (no
Inventor
Joseph Paul Burkhart
John O'neal Johnston
Norton Paul Peet
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of NO911236D0 publication Critical patent/NO911236D0/no
Publication of NO911236L publication Critical patent/NO911236L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0007—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa
    • C07J5/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0059—Estrane derivatives substituted in position 17 by a keto group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C07J1/0074—Esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005—Ketals
    • C07J21/006—Ketals at position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005—Ketals
    • C07J21/008—Ketals at position 17
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0094—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing nitrile radicals, including thiocyanide radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
    • C07J7/002—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa not substituted in position 16

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Reproductive Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Toxicology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Paper (AREA)
NO91911236A 1990-04-02 1991-03-26 Fremgangsmaate for fremstilling av haloethyl-substituerte steroidale enzyminhibitorer. NO911236L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US50319190A 1990-04-02 1990-04-02

Publications (2)

Publication Number Publication Date
NO911236D0 NO911236D0 (no) 1991-03-26
NO911236L true NO911236L (no) 1991-10-03

Family

ID=24001090

Family Applications (1)

Application Number Title Priority Date Filing Date
NO91911236A NO911236L (no) 1990-04-02 1991-03-26 Fremgangsmaate for fremstilling av haloethyl-substituerte steroidale enzyminhibitorer.

Country Status (17)

Country Link
EP (1) EP0450515B1 (de)
JP (1) JP3058710B2 (de)
KR (1) KR0186004B1 (de)
CN (1) CN1055365A (de)
AT (1) ATE124952T1 (de)
AU (1) AU636023B2 (de)
CA (1) CA2038985C (de)
DE (1) DE69111108T2 (de)
ES (1) ES2077097T3 (de)
FI (1) FI911529L (de)
HU (1) HUT57232A (de)
IE (1) IE911062A1 (de)
IL (1) IL97696A0 (de)
NO (1) NO911236L (de)
NZ (1) NZ237559A (de)
PT (1) PT97202A (de)
ZA (1) ZA912235B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4433374A1 (de) * 1994-09-20 1996-03-21 Hoechst Ag 17-Desoxi-corticosteroid-21-/O/-Carbonsäure- ester, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3213085A (en) * 1962-06-12 1965-10-19 Syntex Corp 19-lower alkyl-delta4-pregnen-20-one derivatives
US3449381A (en) * 1962-06-12 1969-06-10 Syntex Corp 19-oxo- and 19-lower alkyl-19-oxoandrostane derivatives
GB8531747D0 (en) * 1985-12-24 1986-02-05 Erba Farmitalia 10beta-alkynylestrene derivatives
GB8531743D0 (en) * 1985-12-24 1986-02-05 Erba Farmitalia 10beta-halo-alkynyl-estrene derivatives

Also Published As

Publication number Publication date
CN1055365A (zh) 1991-10-16
CA2038985A1 (en) 1991-10-03
ZA912235B (en) 1991-12-24
HU911038D0 (en) 1991-10-28
JP3058710B2 (ja) 2000-07-04
DE69111108T2 (de) 1996-01-18
FI911529A7 (fi) 1991-10-03
IL97696A0 (en) 1992-06-21
PT97202A (pt) 1991-11-29
NO911236D0 (no) 1991-03-26
EP0450515A3 (en) 1992-09-30
ES2077097T3 (es) 1995-11-16
ATE124952T1 (de) 1995-07-15
FI911529A0 (fi) 1991-03-28
EP0450515A2 (de) 1991-10-09
AU636023B2 (en) 1993-04-08
IE911062A1 (en) 1991-10-09
HUT57232A (en) 1991-11-28
FI911529L (fi) 1991-10-03
EP0450515B1 (de) 1995-07-12
JPH04253994A (ja) 1992-09-09
KR910018402A (ko) 1991-11-30
CA2038985C (en) 2002-10-15
KR0186004B1 (ko) 1999-04-01
AU7378491A (en) 1991-10-03
NZ237559A (en) 1993-04-28
DE69111108D1 (de) 1995-08-17

Similar Documents

Publication Publication Date Title
DK0599444T3 (da) Dobbeltvirkende inhibitorer
DE69709938D1 (de) N-benzylpiperidin- und tetrahydropyridin-derivate
ATE192649T1 (de) Stereochemische wortmanninderivate
IL135536A0 (en) Ortho-anthranilamide derivatives and pharmaceutical compositions containing the same
NO902394L (no) Fremgangsmaate for fremstilling av pyranyl-cyanoguanidin-derivater.
NO892678D0 (no) Fremgangsmaate for fremstilling av 19-substituerte progesteronderivater.
NO911236D0 (no) Fremgangsmaate for fremstilling av haloethyl-substituerte steroidale enzyminhibitorer.
BG103271A (en) Derivatives of n-(benzothiazol-2-yl) piperidine-1-ethaneamines, method for their preparation and application as therapeutical means
FI915623A0 (fi) 2b,19-etylenbryggsteroider som aromatasinhibitorer.
NO892679D0 (no) Fremgangsmaate for fremstilling av 19-fluor- eller cyano- 21-hydroxyprogesteronderivater.